Clinical heterogeneity, unpredictable course and flares are characteristics of systemic lupus
erythematosus (SLE). Although SLE is—by and large—a systemic disease, occasionally it …

Systemic lupus erythematosus (SLE) is a multiorgan disease with protean manifestations.
Because SLE is uncommon and heterogeneous, its diagnosis can pose a considerable …

Immune responses against endogenous nuclear antigens are characteristic of systemic
lupus erythematosus (SLE), a highly pleiomorphic disease predominantly affecting young …

Systemic lupus erythematosus (SLE) is a complex autoimmune multisystemic disease of
great clinical heterogeneity and significant potential morbidity and mortality. Although the …

The current treatment approach for systemic lupus erythematosus (SLE), as outlined in the
recommendations by international medical associations including EULAR and the ACR, is …

The EULAR/ACR 2019 classification criteria for SLE constitute a current and optimized
clinical approach to SLE classification. Classification is still not based on molecular …

OBJECTIVE: To provide an up-to-date review of the etiology, epidemiology, clinical features,
diagnostic findings, and treatment options for systemic lupus erythematosus (SLE). DATA …

Systemic lupus erythematosus (SLE) is an autoimmune disease of diverse manifestations,
with onset usually in young women in the third to fourth decade of life. The chronic nature of …

Objective Systemic lupus erythematosus (SLE) presents with nonspecific signs and
symptoms that are also found in other conditions. This study aimed to evaluate …

Systemic lupus erythematosus (SLE) is a devastating autoimmune disease that can result in
substantial morbidity and mortality. Diagnosis and treatment of SLE are clinical challenges …